EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk‐stratification and management-Reference-Cited by-同舟云学术

EBV‐positive diffuse large B‐cell lymphoma, not otherwise specified: 2020 update on diagnosis, risk‐stratification and management

Author:

Beltran Brady E.¹²,Castro Denisse¹²,Paredes Sally¹²,Miranda Roberto N.³,Castillo Jorge J.⁴^ORCID

Affiliation:

1. Department of Oncology and Radiotherapy Hospital Nacional Edgardo Rebagliati Martins Lima Peru

2. Centro de Investigación de Medicina de Precision, Universidad San Martin de Porres Lima Peru

3. Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston Texas USA

4. Division of Hematologic Malignancies Dana‐Farber Cancer Institute, Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Hematology

Link

Reference91 articles.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Immunologic Therapies in Development for EBV Driven Lymphoid Malignancies;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21